12 Results for "

KS cells

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "KS cells" in MCE Product Catalog:

Cat. No.: HY-P6292
CAS No.: 2724212-01-3
Research Areas:  

Neurological Disease Cancer

KS-133 is a bicyclic peptide with VIPR2 antagonistic activity that can cross the blood-brain barrier. KS-133 selectively blocks VIPR2-mediated Gq/Ca, Gs/cAMP, cAMP/PKA/ERK and PI3K/AKT/GSK3β signaling pathways. KS-133 inhibits VIPR2 agonist-induced CREB phosphorylation in the prefrontal cortex of mice. KS-133 shifts the polarization direction of macrophages toward M1. KS-133 attenuates cancer cell proliferation and reduces the cell cycle distribution level at the S-M phase. KS-133 exerts antitumor effects in a mouse model of colorectal cancer. KS-133 reverses cognitive decline in mouse models of psychiatric disorders. KS-133 can be used for research related to schizophrenia, colorectal cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-146682
CAS No.: 2408477-54-1
Purity:  99.61%
Research Areas:  

Cancer

KS100 is a potent ALDH inhibitor with IC50s of 230, 1542, 193 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS100 shows antiproliferative and anticancer effects with low low toxic. KS100 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS10600 induces apoptosis and cell cycle arrest at the G2/M phase .
loading...
    loading...
Cat. No.: HY-146683
CAS No.: 2408477-50-7
Purity:  99.31%
Research Areas:  

Cancer

KS106 is a potent ALDH inhibitor with IC50s of 334, 2137, 360 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS106 induces apoptosis and cell cycle arrest at the G2/M phase .
loading...
    loading...
Cat. No.: HY-P10847
CAS No.: 2549046-46-8
Target:  

Ras

Research Areas:  

Cancer

KS-58 is a KRpep-2d (HY-P3277) derivative. KS-58 is a K-Ras (G12D) inhibitory peptide that selectively binds K-Ras. KS-58 can enter cells and block intracellular Ras interaction with effector proteins. KS-58 inhibits the proliferation of tumor cells and has antitumor activity .
loading...
    loading...
Cat. No.: HY-N16442
CAS No.: 428439-25-2
Pyrrocidine B (Compound 6), an alkaloid, is a microbial secondary metabolite. Pyrrocidine B can be isolated from the endophytic fungus Neonectria ramulariae Wollenw KS-246. Pyrrocidine B has significant cytotoxicity against leukemia cells (IC50 of 4.6  μM for HL60 cells) with a weak Prolyl oligopeptidase (POP) inhibitory activity .
loading...
    loading...
Cat. No.: HY-145041
CAS No.: 2201098-03-3
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology Cancer

HPK1-IN-15 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-15 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2018049200A1, compound 50) .
loading...
    loading...
Cat. No.: HY-145042
CAS No.: 2294965-95-8
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology Cancer

HPK1-IN-16 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-16 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019051199A1, compound 39) .
loading...
    loading...
Cat. No.: HY-145044
CAS No.: 2403600-07-5
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology Cancer

HPK1-IN-17 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-17 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019238067A1, compound 73) .
loading...
    loading...
Cat. No.: HY-145045
CAS No.: 2403598-42-3
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology Cancer

HPK1-IN-18 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-18 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019238067A1, compound 1) .
loading...
    loading...
Cat. No.: HY-117612
CAS No.: 1344698-28-7
Target:  

Microtubule/Tubulin Akt

Research Areas:  

Cancer

KS-99 is a dual inhibitor with both tubulin polymerization inhibitory activity and Akt pathway inhibitory activity. KS-99 inhibits cancer cell proliferation and induces cancer cell apoptosis. KS-99 can be used in research related to colorectal cancer, breast cancer, lung epithelial cancer and melanoma .
loading...
    loading...
Cat. No.: HY-117671
CAS No.: 121242-02-2
Research Areas:  

Metabolic Disease

KS IV is a cyclolignan derivative and antigonadotropic agent. KS IV exhibits activity against pregnant mare serum gonadotropin (PMSG) but shows no activity against luteinizing hormone (LH). KS IV abolishes the stimulatory effect of PMSG on testosterone release from isolated mouse Leydig cells. KS IV can be used in studies on gonadotropin-regulated endocrine functions .
loading...
    loading...
Cat. No.: HY-165521
CAS No.: 132032-67-8
Research Areas:  

Cancer

AGN-190121 is a selective RARβ/γ retinoid agonist that inhibits IL-6 expression and cell proliferation in cancer cells by antagonizing NF-IL6. AGN-190121 can be used for the research of Kaposi's sarcoma .
loading...
    loading...
  • 1